Colorectal Cancer Market in North America report 2027 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Colorectal Cancer Market – By Modality

1.3.2 North America Colorectal Cancer Market – By End User

1.3.3 North America Colorectal Cancer Market – By Country

2. North America Colorectal Cancer Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Colorectal Cancer– Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Expert Opinion

5. North America Colorectal Cancer Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Colorectal Cancer

5.1.2 New Product Launches

5.1.3 Benefits Offered by Generic Drugs

5.2 Market Restraints

5.2.1 Pricing Pressure on Drug Manufacturers

5.3 Future Trends

5.3.1 Inclination Toward Personalized Medicine

5.4 Impact Analysis

6. North America Colorectal Cancer Market– North America Analysis

6.1 North America Colorectal Cancer Market Revenue Forecast and Analysis

6.1.1 Overview

7. North America Colorectal Cancer Market Analysis – By Modality

7.1 Overview

7.2 North America Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)

7.3 Diagnosis Type

7.3.1 Overview

7.3.2 Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 Immunohistochemistry

7.3.3.1 Overview

7.3.3.2 Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 Stool Test

7.3.4.1 Overview

7.3.4.2 Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Flexible Sigmoidoscopy

7.3.5.1 Overview

7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6 Colonoscopy

7.3.6.1 Overview

7.3.6.2 Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.7 CEA Test

7.3.7.1 Overview

7.3.7.2 CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.8 Other Test

7.3.8.1 Overview

7.3.8.2 Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapy Type

7.4.1 Overview

7.4.2 North America Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Chemotherapy

7.4.3.1 Overview

7.4.3.2 Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.3 Alkylating Agent

7.4.3.3.2 Overview

7.4.3.3.3 Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.4 Antimetabolites

7.4.3.4.2 Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.5 Others

7.4.3.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Immunotherapy

7.4.4.1 Overview

7.4.4.2 Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.3 Panitumumab

7.4.4.3.2 Overview

7.4.4.3.3 Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.4 Cetuximab

7.4.4.4.2 Overview

7.4.4.4.3 Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.5 Bevacizumab

7.4.4.5.2 Overview

7.4.4.5.3 Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.6 Others

7.4.4.6.2 Overview

7.4.4.6.3 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Chemoprotectant

7.4.5.1 Overview

7.4.5.2 Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6 Others

7.4.6.1 Overview

7.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Imaging Type

7.5.1 Overview

7.5.2 North America Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.3 Computed Tomography (CT)

7.5.3.1 Overview

7.5.3.2 Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.4 Magnetic Resonance Imaging (MRI)

7.5.4.1 Overview

7.5.4.2 Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.5 Others

7.5.5.1 Overview

7.5.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Colorectal Cancer Market Revenue and Forecast To 2028 – By End User

8.1 Overview

8.2 North America Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Diagnostic and Research Laboratories

8.4.1 Overview

8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Colorectal Cancer Market Revenue and Forecast to 2028 – Country Analysis

9.1 North America: Colorectal Cancer Market

9.1.1 Overview

9.1.2 North America: Colorectal Cancer Market, by Country, 2022 & 2028 (%)

9.1.2.1 US: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.2 US: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.3 US: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.2.1.3.1 US: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.2.1.3.2 US: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)

9.1.2.1.3.2.1 US: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)

9.1.2.1.3.2.2 US: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.2.1.3.3 US: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)

9.1.2.1.4 US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

9.1.2.2 Canada: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.2 Canada: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.3 Canada: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.2.2.3.1 Canada: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.2.2.3.1.1 Canada: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)

9.1.2.2.3.1.2 Canada: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)

9.1.2.2.3.2 Canada: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)

9.1.2.2.4 Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

9.1.2.3 Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.2 Mexico: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.3 Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.2.3.3.1 Mexico: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.2.3.3.2 Mexico: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)

9.1.2.3.3.2.1 Mexico: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)

9.1.2.3.3.2.2 Mexico: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.2.3.3.3 Mexico: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)

9.1.2.3.4 Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)

10. Colorectal Cancer Market – Industry Landscape

10.1 Overview

10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028

10.3 Organic Developments

10.3.1 Overview

10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028

10.4 Inorganic Developments

10.4.1 Overview

10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028

11. Company Profiles

11.1 Epigenomics AG

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Clinical Genomics Technologies Pty. Ltd.

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Amgen Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 F. HOFFMANN-LA ROCHE LTD.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Bruker Corporation

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Quest Diagnostics Incorporated

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Volitionrx Limited

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. US: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

Table 2. US: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. US: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 4. US: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 5. US: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)

Table 6. US: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 7. US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

Table 8. Canada: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

Table 9. Canada: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)

Table 13. Canada: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

Table 15. Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

Table 16. Mexico: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)

Table 20. Mexico: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)

Table 22. Recent Organic Growth Strategies In The Colorectal Cancer Market

Table 23. Recent Inorganic Growth Strategies In The Colorectal Cancer Market

Table 24. Glossary of Terms, North America Colorectal Cancer Market

LIST OF FIGURES

Figure 1. North America Colorectal Cancer Market Segmentation

Figure 2. North America Colorectal Cancer Segmentation, By Country

Figure 3. North America Colorectal Cancer Market Overview

Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In North America Colorectal Cancer Market

Figure 5. US is Expected To Show Remarkable Growth During The Forecast Period

Figure 6. North America Colorectal Cancer Market - PEST Analysis

Figure 7. Comparison of Branded Drugs and Generic Drugs

Figure 8. North America Colorectal Cancer Market Impact Analysis of Drivers And Restraints

Figure 9. North America Colorectal Cancer Market – Revenue Forecasts And Analysis – 2020- 2028

Figure 10. North America Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%)

Figure 11. North America Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. North America Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. North America Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. North America Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. North America Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. North America CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. North America Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. North America Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. North America Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. North America Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. North America Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. North America Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. North America Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. North America Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. North America Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. North America Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. North America Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. North America Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. North America Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. North America Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. North America Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. North America Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%)

Figure 35. North America Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. North America Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. North America: Colorectal Cancer Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million)

Figure 38. North America: Colorectal Cancer Market, By Country, 2022 & 2028 (%)

Figure 39. US: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)

Figure 40. Canada: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)

Figure 41. Mexico: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)

Figure 42. Growth Strategies In The Colorectal Cancer Market, 2022-2028